These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30445560)

  • 21. Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction.
    Lebrun JJ; Ali S; Ullrich A; Kelly PA
    J Biol Chem; 1995 May; 270(18):10664-70. PubMed ID: 7537736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JAK2/STAT5 Pathway Mediates Prolactin-Induced Apoptosis of Lactotropes.
    de Dios N; Orrillo S; Irizarri M; Theas MS; Boutillon F; Candolfi M; Seilicovich A; Goffin V; Pisera D; Ferraris J
    Neuroendocrinology; 2019; 108(2):84-97. PubMed ID: 30376668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of prolactin receptor in GH signaling in breast cancer cells.
    Xu J; Sun D; Jiang J; Deng L; Zhang Y; Yu H; Bahl D; Langenheim JF; Chen WY; Fuchs SY; Frank SJ
    Mol Endocrinol; 2013 Feb; 27(2):266-79. PubMed ID: 23192981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional characterization of the intermediate isoform of the human prolactin receptor.
    Kline JB; Roehrs H; Clevenger CV
    J Biol Chem; 1999 Dec; 274(50):35461-8. PubMed ID: 10585417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wild-type offspring of heterozygous prolactin receptor-null female mice have maladaptive β-cell responses during pregnancy.
    Huang C
    J Physiol; 2013 Mar; 591(5):1325-38. PubMed ID: 23247113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutant prolactin receptor and familial hyperprolactinemia.
    Newey PJ; Gorvin CM; Cleland SJ; Willberg CB; Bridge M; Azharuddin M; Drummond RS; van der Merwe PA; Klenerman P; Bountra C; Thakker RV
    N Engl J Med; 2013 Nov; 369(21):2012-2020. PubMed ID: 24195502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Internalization of prolactin receptor and prolactin in transfected cells does not involve nuclear translocation.
    Perrot-Applanat M; Gualillo O; Buteau H; Edery M; Kelly PA
    J Cell Sci; 1997 May; 110 ( Pt 9)():1123-32. PubMed ID: 9175708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
    Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
    Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.
    Xu J; Zhang Y; Berry PA; Jiang J; Lobie PE; Langenheim JF; Chen WY; Frank SJ
    Mol Endocrinol; 2011 Apr; 25(4):597-610. PubMed ID: 21310852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity.
    Zhao D; Ma G; Zhang X; He Y; Li M; Han X; Fu L; Dong XY; Nagy T; Zhao Q; Fu L; Dong JT
    J Biol Chem; 2016 Jun; 291(24):12809-12820. PubMed ID: 27129249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prolactin receptor scaffolds Janus kinase 2 via co-structure formation with phosphoinositide-4,5-bisphosphate.
    Araya-Secchi R; Bugge K; Seiffert P; Petry A; Haxholm GW; Lindorff-Larsen K; Pedersen SF; Arleth L; Kragelund BB
    Elife; 2023 May; 12():. PubMed ID: 37232489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The short isoform of PRLR suppresses the pentose phosphate pathway and nucleotide synthesis through the NEK9-Hippo axis in pancreatic cancer.
    Nie H; Huang PQ; Jiang SH; Yang Q; Hu LP; Yang XM; Li J; Wang YH; Li Q; Zhang YF; Zhu L; Zhang YL; Yu Y; Xiao GG; Sun YW; Ji J; Zhang ZG
    Theranostics; 2021; 11(8):3898-3915. PubMed ID: 33664869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
    Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
    Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PRL/PRLR Can Promote Insulin Resistance by Activating the JAK2/STAT5 Signaling Pathway.
    Wang PY; Jin CC; Liu C; Zhao ZJ; Yang HY
    Comput Math Methods Med; 2022; 2022():1456187. PubMed ID: 36238467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different intracellular signalling pathways triggered by an anti-prolactin receptor (PRLR) antibody: Implication for a signal-specific PRLR agonist.
    Kan QE; Su Y; Yang H; Man H
    Int J Biol Macromol; 2016 Jan; 82():892-7. PubMed ID: 26526176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness.
    Kavarthapu R; Dufau ML
    Front Endocrinol (Lausanne); 2022; 13():949396. PubMed ID: 36187116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a new anti-prolactin receptor (PRLR) antibody, F56, which can serve as a PRLR antagonist.
    Cui H; Ma YZ; Wang Y; Song M; Zhang H
    Int J Biol Macromol; 2017 Feb; 95():1223-1227. PubMed ID: 27829125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
    Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
    Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cells with minimal expression of the JAK/STAT pathway related proteins STAT5a and the prolactin receptor: evidence of an alternate prolactin receptor isoform in breast disease.
    Bratthauer GL; Stamatakos MD; Vinh TN
    Protein Pept Lett; 2010 Jan; 17(1):104-8. PubMed ID: 20214633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dominant negative and cooperative effects of mutant forms of prolactin receptor.
    Perrot-Applanat M; Gualillo O; Pezet A; Vincent V; Edery M; Kelly PA
    Mol Endocrinol; 1997 Jul; 11(8):1020-32. PubMed ID: 9212050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.